To
view an enlargement, click on the image.
Table
1
Risk Factors for Ectopic Pregnancy
Prior ectopic
In-vitro fertilization
Tubal ligation
Intra-uterine contraceptive device
Cigarette smoking
Multiple sex partners
Pelvic inflammatory disease
Endometriosis
Location
of Ectopic Pregnancies
Approximately
80% of ectopic pregnancies occur in the ampullary portion of the fallopian
tube; 10% are in the isthmus; 5% are fimbrial in location and 2-4% are cornual.
Ovarian, cervical and abdominal pregnancies are rare (Breen, 1970).
Clinical
Findings
Historically,
pelvic pain was the most common symptom of an ectopic pregnancy. Initially,
the pain may be localized to the side of the ectopic. After rupture, the pain
becomes more diffuse. With the earlier diagnosis of ectopic pregnancies, a
skipped menstrual cycle or early first trimester spotting may be a patient's
only initial complaint. The classic triad of vaginal bleeding, adnexal tenderness,
and an adnexal mass is present in less than 30% of ectopic pregnancies (Kim,
1987).
Quantitative
B-hCG Levels
Serum B-hCG
can be detected by 6 days after conception (Daya, 1987). While the B-hCG of
ectopic pregnancies are generally lower than for normal pregnancies, there
is significant overlap. The B-hCG level of unruptured (1190mIU/ml) and ruptured
(4160 mIU/ml) ectopic pregnancies are significantly different (Ackerman, 1982).
Ectopic pregnancies with very low B-hCG levels are unlikely to rupture and
may spontaneously resolve (Hay, 1989). However, in cases when gestational
age is uncertain, a chronic ectopic pregnancy should be considered. Recurrent
small episodes of bleeding result in a gradual disintegration of the tubal
wall; a pelvic mass eventually forms. Since the trophoblastic tissue may have
died, the B-hCG level may be low to absent (Abramov, 1997).
There is a direct
correlation between gestational sac size and the exponential rise in B-hCG
during the first 5 weeks of pregnancy. Hence, by comparing ultrasound findings
with B-hCG levels, the concept of a "discriminatory zone" was developed. With
transvaginal sonography a gestational sac is usually visualized at a serum
B-hCG level between 1000 and 2000 mIU/ml. However, technical factors (multiple
gestation, leiomyomas, subchorionic hemorrhage) and biologic variability in
singleton gestations may result in a normal intrauterine gestational sac not
being detected until a greater B-hCG level is obtained. In general, the 95%
confidence interval for the detection of a normal intrauterine gestational
sac is 3000 mIU/ml (Kadar, 1994; Shapiro, 1992).
Sonographic
Findings
A normal intrauterine
gestational sac is embedded below the mid-line endometrial stripe. The hormonal
changes associated with a pregnancy results in an endometrial fluid collection
(pseudo-sac) in 8% of ectopic pregnancies (Hill, 1990) (Figure 2). A low-level
echo pattern may be observed in a pseudogestational sac, particularly in a
patient with a high B-hCG level (Thorsen, 1990).
To
view an enlargement, click on the image.
Figure
2. A debris-filled pseudogestational sac associated with an ectopic gestation.
The presence
of an embryo with cardiac activity outside of the uterus is diagnostic of
an ectopic pregnancy (Figure 3). In the past this presentation of an ectopic
pregnancy occurred between 8% -26% of the time (Timor-Tritsch, 1989; Atri,
1992). Today an "echogenic ring" (Figure 4) has been reported more commonly;
occurring in 40% to 70% of ectopic pregnancies (Atri 1992; Fleischer, 1990).
Because of there approximation, it is sometimes difficult to distinguish between
an ectopic "echogenic ring" adjacent to an ovary and a corpus luteum. The
transvaginal transducer can be used to determine if the "echogenic ring" moves
with or is independent of, the ovary.
To
view an enlargement, click on the image.
Figure 3.
An ectopic pregnancy with a heart rate of 115 beats/minute.
To
view an enlargement, click on the image.
Figure 4.
The characteristic echogenic ring of an ectopic pregnancy (arrows). The patient's
B-hCG was 2100 mIU/ml.
Once an ectopic
pregnancy has ruptured, a complex adnexal mass of mixed echogenicity (Figure
5) may be imaged. Particulate cul-de-sac fluid indicates associated intraperitoneal
hemorrhage (Nyberg, 1991).
Because of the
surrounding myometrium, cornual ectopics can grow to a large size before becoming
symptomatic. Since a cornual pregnancy is not located within the endometrial
cavity, transvaginal sonography will reveal an "interstitial line" that extends
from the uterine cavity to the cornual gestational sac (Figure 6) (Frates,
1995).
To
view an enlargement, click on the image.
Figure 5.
An ectopic pregnancy presenting as a complex right adnexal mass (u = uterus)
To
view an enlargement, click on the image.
Figure 6.
A left cornual pregnancy at 11 weeks' gestation (arrow = endometrial cavity).
In order to
diagnose a cervical pregnancy, the embryo/fetus must not be within the uterine
cavity and the placenta must be attached to the cervix (Figure 7). The differential
diagnosis would include an imminent miscarriage. The presence of cardiac activity
in a cervically located gestational sac would confirm the diagnosis. When
cardiac activity is not present, a follow-up scan in 24 hours would exclude
a diagnosis of an imminent miscarriage. Cervical ectopics occur more frequently
after invitro fertilization (Parente 1983; Ginsburg, 1994).
To view an enlargement, click on the image.
Figure
7. A cervical ectopic pregnancy 2 cm from the internal cervical os. A yolk
sac (arrow) is visualized within the gestational sac.
Ovarian pregnancies
result from either ovum fertilization within the ovary (primary) or the implantation
of a tubal abortion on an ovary (secondary). The sonographic appearance of
an ovarian pregnancy can vary from an "echogenic ring" fixed to the ovary
to a complex adnexal mass that involves the ovary. It may, therefore, be difficult
to distinguish a hemorrhagic ovarian cyst from an ovarian pregnancy (Malinger,
1988). Since the fallopian tube is not affected, an ovarian pregnancy is not
a risk factor for a repeat ectopic pregnancy.
An abdominal
pregnancy occurs when a tubal abortion implants on a peritoneal cavity and
continues to grow. While anhydramnios is common, it is not an invariable finding
with abdominal pregnancies. Additional sonographic signs include a failure
to visualize the uterine wall around a pregnancy; an abnormal fetal lie; and
an empty uterus with an adjacent fetus. A pregnancy in one horn of a bicornuate
or didelphysis uterus may mimic an abdominal pregnancy (Ombelet, 1988; Stanley
1986).
Color
Doppler
Vascular flow
around an ectopic pregnancy is directly related to the amount of viable trophobastic
tissue present. In the classic case there is a "ring of fire" surrounding
the ectopic (Figure 8). A corpus luteum may have a similar sonographic appearance.
There is more flow surrounding an established ectopic pregnancy. However,
in these cases the "echogenic ring" would be most apparent on standard two-dimensional
sonography. In 1 of 65 cases color Doppler identified an ectopic pregnancy
that was not identified with gray scale (Pellerito, 1992). While color Doppler
has been a useful adjunct, it has not changed the diagnostic accuracy achieved
with the combination of B-hCG levels and transvaginal sonography (Tekay, 1992;
Bourne, 1991).
Figure 8.
The "ring of fire" (power Doppler) associated with an ectopic pregnancy.
To
view an enlargement,
click on the image.
Management
The traditional
management for ectopic pregnancies has been surgical, i.e. salpingectomy or
linear salpingostomy. With the latter approach, residual chorionic villi may
remain. The prevalence of a persistent ectopic pregnancy is 2%-5% with linear
salpingostomy at laparotomy in contrast to 3% - 20% at laparoscopy (Seifer,
1993). Prophylactic methotrexate within 24 hours of salpingostomy significantly
reduces the incidence of persistent ectopic pregnancy (Graczykowski, 1997).
Medical management
of ectopic pregnancies consists of the systemic administration of methotrexate
(50 mg/m2 of body surface area, IM). A falling B-hCG level of > 15% between
days 4 and 7 after treatment is considered successful therapy; B-hCG levels
are then followed weekly until they are not detectable. When the B-hCG level
fails to fall 15% , either initially or when the subsequent weekly follow-up
levels are obtained, a repeat dose of methotrexate is given. Successful treatment
of ectopic pregnancies with methotrexate has been reported in 85.7% to 94.2%
of selected cases (Brumsted, 1996). All of the reports have not been this
successful. In a systematic review of single-dose intramuscular methotrexate
for ectopic pregnancy, Parker et al (1998) reported a pooled success rate
of 71%. Serious complications, including 1 maternal death, have occurred after
methotrexate therapy for ectopic pregnancy. When methotrexate is successful,
post treatment hysterosalpingograms have demonstrated tubal patency on the
side of the ectopic in 82.3% of patients (Stoval, 1993).
References
1. Abramov Y,
Nadjar M, Shushan A, Prus D, Anteby SO. Doppler findings in chronic ectopic
pregnancy: case report. Ultrasound Obstet Gynecol 1997;9:344-346.
2. Ackerman
R, Deutsch S, Krumholz B. Levels of human chorionic gonadotropin in unruptured
and ruptured ectopic pregnancy. Obstet Gynecol 1982;60:13-14.
3. Atri M, deStempel
J, Bret P. Accuracy of transvaginal ultrasonography for the detection of hematosalpinx
in ectopic pregnancy. J Clin Ultrasound 1992;20:255-61.
4. Bourne TH.
Transvaginal color Doppler in gynecology. Ultrasound Obstet Gynecol 1991;1:359-73.
5. Breen JL.
A 21 year survey of 654 ectopic pregnancies. Am J Obstet Gynecol 1970;106:1004-19.
6. Brumsted
JB. Managing ectopic pregnancy non-surgically. Cont Ob Gyn 1996;41:43-56.
7. Daya S. Human
chorionic gonadotropin increase in normal pregnancy. Am J Obstet Gynecol 1987;156:286-90.
8. Filly RA.
Ectopic pregnancy: the role of sonography. Radiology 1987;162:661-668.
9. Fleischer
AC, Pennell RG, McKee MS, Worrell JA, Keefe B, Herbert CM, Hill GA, Cartwright
PS, Kept DM. Ectopic pregnancy: features at transvaginal sonography. Radiology
1990;174:375-8.
10. Frates MC,
Laing FC. Sonographic evaluation of ectopic pregnancy: an update. AJR 1995;165:251-9.
11. Ginsburg
ES, Frates MC, Rein MS, Fox JH, Hornstein MD, Friedman AJ. Early diagnosis
and treatment of cervical pregnancy in an in-vitro fertilization program.
Fert Steril 1994;61:966-969.
12. Graczykowski
JW, Mishell DR Jr. Methotrexate prophylaxsis of persistent ectopic pregnancy
after conservative treatment by salpingostomy. Obstet Gynecol 1997;89:118-122.
13. Hay DL,
DeCrespigny L, McKenna M. Monitoring early pregnancy with transvaginal ultraosund
and choriogonadotropin levels. Aust NZ J Obstet Gynecol 1989;29:165-67.
14. Hill LM,
Kislak S, Martin JG. Transvaginal sonographic detection of the pseudo-gestational
sac associated with ectopic pregnancy. Obstet Gynecol 1990;75:986-88.
15. Kadar N,
Bohrer M, Kemmann E, Shelden R. The discriminatory human chorionic gonadotropin
zone for endovaginal sonography: a prospective, randomized study. Fertil Steril
1994;61:1016-20.
16. Kim DS,
Chung SR, Park MI, Kim YP. Comparative review of diagnostic accuracy in tubal
pregnancy: A 14-year study of 1040 cases. Obstet Gynecol 1987;70:547-54.
17. Malinger
G, Achiron R, Treschan O, Zakut H. Ovarian pregnancy - ultrasonographic diagnosis.
Acta Obstet Gynecol Scand 1988;67:561-563.
18. Nazari A,
Askari HA, Check JH, O'Shauhnessy A. Embryo transfer technique as a cause
of ectopic pregnancy in in-vitro fertilization. Fertil Steril 1993;60:919-21.
19. NCHS: Advanced
Report of Final Mortality Statistics 1992 (Report No. 43, suppl). Hyattsville,
MD, US Dept of Health and Human Services, Public Health Service, CDC, 1994.
20. Nyberg DA,
Hughes MP, Mack LA, Wang KY. Extra-uterine findings of ectopic pregnancy at
transvaginal ultrasound: importance of echogenic fluid. Radiol 1991;178:823-6.
21. Ombelet
W, Vandermerwe JV, Van Assche FA. Advanced extra-uterine pregnancy: description
of 38 cases with literature survey. Obstet Gynecol Surv 1988;43:386-397.
22. Parente
JT, Ou C-S, Levy J, Legatt E. Cervical pregnancy analysis: a review and report
of five cases. Obstet Gynecol 1983;62:79-82.
23. Parker J,
Bisits A, Proietto AM. A systematic review of single-dose intramuscular methotrexate
for the treatment of ectopic pregnancy. Aust NZJ Obstet Gynecol 1998;38:145-150.
24. Pellerito
JS, Taylor KJ, Quedens-Case C, Hammers LW, Scoutt LM, Ramos IM, Meyer W. Ectopic
pregnancy: Evaluation with endovaginal color flow imaging. Radiology 1992;183:407-11.
25. Seifer DB,
Gutman JN, Grant WD, Kamps CA, DeCherney AH. Comparison of persistent ectopic
pregnancy after laparoscopic salpingostomy versus salpingostomy at laparotomy
for ectopic pregnancy. Obstet Gynecol 1993;81:378-382.
26. Senterman
M, Jiboth R, Tulandi T. Histopathologic study of ampullary and isthmic tubal
ectopic pregnancy. Am J Obstet Gynecol 1988;159:939-41.
27. Shapiro
BS, Escobar M, Makuch R, Lavy G, DeCherney AH. A model-based prediction for
transvaginal ultrasonographic identification of early intrauterine pregnancy.
Am J Obstet Gynecol 1992;166:1495-500.
28. Stabile
I, Gradzinskas JG. Ectopic pregnancy: a review of incidence, etiology, and
diagnostic aspects. Obstet Gynecol Surv 1990;45:335-47.
29. Stanley
JH, Horger EO III, Fagan CJ, Andriole JG, Fleischer AC. Sonographic findings
in abdominal pregnancy. AJR 1986;147:1043-1046.
30. Stovall
TG, Ling FW. Single-dose methotrexate: an expanded clinical trial. Am J Obstet
Gynecol 1993;168:1759-65.
31. Tekay A,
Jouppila P. Color doppler flow as an indicator of trophoblastic activity in
tubal pregnancies detected by transvaginal ultrasound. Obstet Gynecol 1992;80:995-9.
32. Thorsen
MK, Lawson TL, Aiman EJ, Miller DP, McAsey ME, Erickson SJ, Quiroz F, Perret
RS. Diagnosis of ectopic pregnancy: endovaginal versus transabdominal sonography.
AJR 1990;155:307-10.
33. Timor-Tritsch
IA, Yeh MN, Peisner DB, Lesser KB, Slavik BA. The use of transvaginal ultrasonography
in the diagnosis of ectopic pregnancy. Am J Obstet Gynecol 1989;161:159-61.
TAKE
THE QUIZ
Our
online courses are free of charge.
If you wish to earn CME credit there you will be asked to make payment by
major credit card after successful completion of the quiz. The charge is $25
for one program, $60 for four programs and $80 for eight programs. If you
purchase multiple programs you may take them at any time.
IAME
Statement on Privacy and Confidentiality
